We are one of the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Our products offering comprises of 113 products across multiple markets and therapeutic areas. All our products range across various therapeutic segments, including anesthesia, critical care, anti-infective, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology. We offer injectables in various delivery systems, such as glass and plastic bottles, vials, ampoules, pre-filled syringes and non-PVC and PVC bags.

Our Company commissioned its first manufacturing plant, Clarion I, in 2002. We have since expanded our operations to four manufacturing facilities (Clarion I to IV). A fifth manufacturing facility, Clarion V, is currently under construction and we expect it to be operational by the third quarter of 2011.

In order to expand our production capabilities we in the process or raising Rs. 3,000 million via a public offering of shares; we have submitted the DRHP with SEBI on 19th April 2010.

In order to facilitate our future investors this section has been dedicated to provide information that will be useful to take an informed decision.